Extra pulmonary boosting in chronic obstructive pulmonary disease: leverage of piracetam as an adjunctive therapy on respiratory and neuropsychiatric functions in patients with chronic obstructive pulmonary disease

Background Promotion of central control of respiration might contribute in minimization of chronic obstructive lung disease disability. Objectives Our study was done to evaluate the effect of oral supplementation of piracetam tablets in low dose (400 mg twice daily) versus high dose (1200 mg twice d...

Full description

Bibliographic Details
Main Authors: Ahmed M Abumossalam, Amr F Sheta, Sahar E Ahmed, Dalia A Elhalaby, Amro A Moawad
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Egyptian Journal of Chest Disease and Tuberculosis
Subjects:
Online Access:http://www.ejcdt.eg.net/article.asp?issn=0422-7638;year=2021;volume=70;issue=1;spage=60;epage=70;aulast=Abumossalam